Bile Duct Cancer Market Growth, Price, Demand and Forecasts To 2025 Bile Duct Cancer Market - Global Industry Analysis

Bile Duct Cancer Market - Global Industry Analysis, Size, Share,
Growth, Trends, and Forecast 2017 – 2025
Bile duct is a network of tube that connects the liver to the gall bladder. Bile duct carries a fluid
called bile which is synthesize in the liver and stored in the gall bladder. The primary function of bile is
breakdown of fats during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The
particular cause of bile duct cancer is unknown but few factors that are responsible for developing bile
duct cancer are long-term inflammation in the liver, biliary stones, abnormalities in bile duct such as
cysts, infection with liver flukes parasite that causes infection in bile duct leading to cancer, and
exposure to harmful chemicals and toxins. Major symptoms associated with bile duct cancer includes
jaundice, weight loss, loss of appetite, discoloration of urine and stool, abdominal pain, itching, and
fever.
The global bile duct cancer market is driven by increase in prevalence of bile duct cancer patients
across the globe, technological advancement in the health care sector, and rise in health care
expenditure in developed countries. In addition, new research and development by pharmaceutical
companies for availability of affordable treatment through extensive research is a major driver of the
market. However, high cost associated with clinical trials and long duration in approvals of drugs acts
as major barriers for the market growth.
Request for brochure of this report -
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22898
The global bile duct cancer market has been categorized based on treatment type, type of cancer,
end-user, and region. Based on treatment type, the global market is segmented into surgery,
chemotherapy, and radiation therapy. Surgery treatment includes surgical removal of bile ducts, partial
hepatectomy, and in severe cases Whipple procedure and liver transplantation. The chemotherapy
segment can be sub-segmented into 5-fluorouracil, gemcitabine, capecitabine, oxaliplatin, cisplatin,
and combined drug treatment. Factors such as availability of a wide range of chemotherapeutics
agents for treatment of bile ducts cancer and ongoing innovative research work on improvement of
chemotherapy by studying new drugs and new combination of drugs through clinical trials are
anticipated to boost the market growth of the chemotherapy segment during the forecast period.
Based on type of cancer, the market is segmented into intrahepatic bile duct cancer and extrahepatic
bile duct cancer. The formation of cancer inside bile duct within liver is termed as intrahepatic bile duct
cancer. Extrahepatic bile duct is made up of the hilum region and the distal region. Based on location,
the extrahepatic bile duct cancer is sub-segmented into perihilar bile duct cancer and distal
extrahepatic bile duct cancer. On the basis of end-user, the market is segmented into hospitals, clinics,
and others.
Geographically, the global market for bile duct cancer is distributed over North America, Europe, Asia
Pacific, Latin America, and Middle East & Africa. Cancer is one of the leading causes of death in
developed nations. North America holds a significant share of the bile duct cancer market, followed by
Europe, due to advanced discoveries and innovations for treating cancer in early stages. Major factors